Status:
ACTIVE_NOT_RECRUITING
Obstructive Sleep Apnoea and Cardiac Arrhythmias
Lead Sponsor:
University Hospitals Coventry and Warwickshire NHS Trust
Conditions:
Obstructive Sleep Apnea
Cardiovascular Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is a prevelance trial looking at how sleep apnoea affects the heart especially heart rhythms. Previous research shows that patients suffering from sleep apnoea are much more likely to get ...
Detailed Description
Sleep apnoea affects up to 1.5 million adults in the United Kingdom (UK). This puts this population at risk of reduced oxygen levels during sleep, poor sleep and increased breathing effort . All of th...
Eligibility Criteria
Inclusion
- Patients with moderate to severe sleep apnoea who require CPAP as standard care (AHI \>15)
- Patients between the age of 18 and 75
Exclusion
- Patients with a diagnosis of atrial fibrillation (AF), atrial flutter and/or ventricular tachycardia (VT)
- Patients with an ILR already in-situ or an established indication for ILR
- Patients with a palliative diagnosis i.e. life expectancy less than 3 years
- Patients who lack capacity
Key Trial Info
Start Date :
October 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 15 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03866148
Start Date
October 3 2019
End Date
April 15 2025
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Coventry & Warwickshire
Coventry, United Kingdom, CV2 2DX